Snowball logo
logo
TRSS_logo

Terrascend Corp

TRSSF • OTCQX Delisted
-- $$0.00  (0%)
Estimate
EPS
-1.3
Growth
Revenue, YoY
43.26%
Net income, YoY
-252.11%
FCF, YoY
94.52%
Forecast
EPS (FWD)
-0.07
About the company
Ticker
TRSSF
ISIN
CA88105E1088
Country
Canada
Sector (GICS)
Healthcare
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Frequently asked questions

What sector does Terrascend Corp (TRSSF) operate in?

Terrascend Corp belongs to the Healthcare sector and operates in the Food & Drug Retailing industry.

What is Terrascend Corp (TRSSF) Earnings Per Share (EPS)?

The trailing EPS is -$1.30, and the forward EPS is -$0.07.

What is Terrascend Corp (TRSSF) EBITDA?

Terrascend Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 7.03 million.

Does Terrascend Corp (TRSSF) pay dividends?

No. Terrascend Corp does not pay a dividend.

How did Terrascend Corp (TRSSF) perform in its most recent earnings report?

In the last report (June 30, 2023), Terrascend Corp posted an EPS surprise of -66.67% and a revenue surprise of 2.04%.

When is Terrascend Corp (TRSSF) next earnings report?

Terrascend Corp is expected to release its next earnings report on March 31, 2024.